Correlation Between De Rucci and Betta Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both De Rucci and Betta Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining De Rucci and Betta Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between De Rucci Healthy and Betta Pharmaceuticals Co, you can compare the effects of market volatilities on De Rucci and Betta Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in De Rucci with a short position of Betta Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of De Rucci and Betta Pharmaceuticals.

Diversification Opportunities for De Rucci and Betta Pharmaceuticals

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between 001323 and Betta is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding De Rucci Healthy and Betta Pharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Betta Pharmaceuticals and De Rucci is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on De Rucci Healthy are associated (or correlated) with Betta Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Betta Pharmaceuticals has no effect on the direction of De Rucci i.e., De Rucci and Betta Pharmaceuticals go up and down completely randomly.

Pair Corralation between De Rucci and Betta Pharmaceuticals

Assuming the 90 days trading horizon De Rucci is expected to generate 2.48 times less return on investment than Betta Pharmaceuticals. But when comparing it to its historical volatility, De Rucci Healthy is 1.56 times less risky than Betta Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Betta Pharmaceuticals Co is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  4,606  in Betta Pharmaceuticals Co on September 1, 2024 and sell it today you would earn a total of  929.00  from holding Betta Pharmaceuticals Co or generate 20.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy95.65%
ValuesDaily Returns

De Rucci Healthy  vs.  Betta Pharmaceuticals Co

 Performance 
       Timeline  
De Rucci Healthy 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in De Rucci Healthy are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, De Rucci sustained solid returns over the last few months and may actually be approaching a breakup point.
Betta Pharmaceuticals 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Betta Pharmaceuticals Co are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Betta Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

De Rucci and Betta Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with De Rucci and Betta Pharmaceuticals

The main advantage of trading using opposite De Rucci and Betta Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if De Rucci position performs unexpectedly, Betta Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Betta Pharmaceuticals will offset losses from the drop in Betta Pharmaceuticals' long position.
The idea behind De Rucci Healthy and Betta Pharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk